Loxo Oncology
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Loxo Oncology's past years’ income statements indicate that its last revenue has increased compared to the previous period by 351% to $3,520,000. Profit margin reached -4229%. Total operating expenses were $173,696,000.
Profit Margin
| 2014 | 18K | -20.67M | -114844.44% |
|---|---|---|---|
| 2015 | 199K | -35.87M | -18028.14% |
| 2016 | 780K | -72.39M | -9281.79% |
| 2017 | 3.52M | -148.87M | -4229.43% |
LOXO Income Statement (2014 – 2017)
| 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 3.52M | 780K | 199K | 18K |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 3.52M | 780K | 199K | 18K |
Operating exp. | ||||
Research and development | 140.03M | 58.27M | 13.95M | 6.94M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 173.69M | 73.17M | 24.46M | 13.12M |
Operating income | -152.39M | -73.17M | -36.07M | -20.69M |
Other income (expenses), net | 3.52M | 778K | 0 | 41.39M |
Income before tax | -148.87M | -72.4M | -36.07M | 20.7M |
Income tax expense | 3.52M | 778K | 0 | 41.39M |
Net income | -148.87M | -72.39M | -35.87M | -20.67M |
Earnings per share | ||||
Basic EPS | -4.92 | -2.39 | -1.19 | -2.03 |
Diluted EPS | -4.92 | -3.46 | -2.12 | -3.05 |
| Data source | Data source | Data source | Data source |